Posted on March 3rd, 2010 by Beth Backus
About 25% of breast cancers diagnosed in the United States are HER-2–positive. Research has established that the HER-2 phenotype is associated with poor DFS and OS.
Tags: Mayo Clinic Jacksonville
You must be logged-in to the site to post a comment.